Buyang Huanwu Decoction Ameliorates Damage of Erectile Tissue and Function Following Bilateral Cavernous Nerve Injury.
10.1007/s11655-022-3532-9
- Author:
Miao-Yong YE
1
;
Fan ZHAO
2
;
Ke MA
3
;
Li-Juan YAO
4
;
Kang ZHOU
3
;
Jian-Xiong MA
3
;
Bo-Dong LYU
5
;
Zeng-Bao XU
4
Author Information
1. Department of Urology, the First People's Hospital of Wenling, Wenling, Zhejiang Province, 317500, China.
2. Department of Urology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, 226001, China.
3. The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
4. Department of Urology, Huzhou Hospital of Traditional Chinese Medicine, Huzhou, Zhejiang Province, 313000, China.
5. Andrology Laboratory on Integration of Chinese and Western Medicine, Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine, Hangzhou, 310053, China. bodonglv0571@163.com.
- Publication Type:Journal Article
- Keywords:
Buyang Huanwu Decoction;
Chinese medicine;
Jun N-terminal kinase;
cavernous nerve injury;
erectile dysfunction
- MeSH:
Male;
Humans;
Rats;
Animals;
Reactive Oxygen Species;
Tandem Mass Spectrometry;
bcl-2-Associated X Protein;
Rats, Sprague-Dawley;
Erectile Dysfunction/drug therapy*;
Collagen;
Fibrosis;
Disease Models, Animal
- From:
Chinese journal of integrative medicine
2023;29(9):791-800
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:To verify the effect of Buyang Huanwu Decoction (BHD) in ameliorating erectile dysfunction (ED) after radical prostatectomy (RP).
METHODS:The composition of BHD was verified by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS/MS) analysis. Bilateral cavernous nerve crush injury (BCNI) in rats was used to mimic the neurovascular injury occurring after RP. By the envelope method, forty rats were randomly divided into 4 groups as follows: sham (cavernous nerves exposed only), model (BCNI), low-dosage BHD [LBHD, 12.8 g/(kg·d)], and high-dosage BHD [HBHD, 51.2 g/(kg·d)] groups, 10 rats in each group, feeding for 3 weeks respectively. Erectile function was evaluated by measuring intracavernosal pressure (ICP). Changes in the histopathology of corpus cavernosum (CC) were examined by hematoxylin-eosin staining. Meanwhile, the fibrosis of CC was measured by Masson's trichrome staining and Western blot was used to detect the expressions of collagen I, transforming growth factor beta 1 (TGF- β 1) and α-smooth muscle actin (α-SMA). Apoptosis index was detected by terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) and Western blot for determining the expressions of B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X (Bax). The oxidative stress in the CC were assessed by the superoxide dismutase (SOD), malondialdehyde (MDA) and reactive oxygen species (ROS) levels. The proteins expression of c-Jun N-terminal kinase (JNK) and c-Jun were detected by Western blot. In addition, the expression of α-SMA and p-c-Jun in the CC was observed by double immunofluorescence staining.
RESULTS:The UPLC-QTOF-MS/MS analysis showed that BHD contained calycosin-7-O- β -D-glucoside, ononin, calycosin and formononetin. Compared with the model group, LBHD and HBHD treatment improved the ICP and the circumference, area, and weight of CC (P<0.05 or P<0.01). Furthermore, LBHD and HBHD treatments increased CC smooth muscle content and decreased apoptosis index (P<0.05 or P<0.01). LBHD and HBHD also elevated SOD and expression level of α -SMA and Bcl-2, and reduced MDA and ROS levels, as well as expression of TGF- β 1, collagen I, Bax, p-c-JNK, p-JNK in the CC compared with the model group (P<0.05 or P<0.01). The double immunofluorescence staining showed that the fluorescence degree of p-c-Jun in both LBHD and HBHD treatment groups was significantly reduced, whereas the α -SMA expression increased (P<0.05 or P<0.01).
CONCLUSIONS:BHD can improve ED of rats with BCNI, which is related to inhibiting fibrosis, apoptosis, and oxidative stress of CC. The ROS/JNK/c-Jun signaling pathway may play an important role in the process.
